Login to Your Account

Zealand, Lilly Partner on Diabetes Peptide Drugs

By Cormac Sheridan
Staff Writer

Wednesday, September 4, 2013
Zealand Pharma A/S added Eli Lilly and Co. to its roster of big pharma diabetes partners, entering a research collaboration with the Indianapolis-based firm that could eventually lead to a novel, first-in-class therapy.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription